Not available
Quote | Sosei Co Ltd Ord (OTCMKTS:SOLTF)
Last: | $10.526 |
---|---|
Change Percent: | 0.0% |
Open: | $10.526 |
Close: | $10.526 |
High: | $10.526 |
Low: | $10.526 |
Volume: | 3 |
Last Trade Date Time: | 03/18/2024 03:00:00 am |
News | Sosei Co Ltd Ord (OTCMKTS:SOLTF)
Tokyo, Japan and Cambridge, UK, 27 March 2024 – Sosei Group Corporation (“the Company”; TSE: 4565) announces that the re-election of its Board of Directors and Executive Officers was approved at the Company’s 34th Annual Shareholders’ Meeting and a sub...
HTL0033744 has been designed by Sosei Heptares to promote mucosal healing and resolve inflammation in people with IBD Tokyo, Japan and Cambridge, UK, 21 March 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) announces...
Message Board Posts | Sosei Co Ltd Ord (OTCMKTS:SOLTF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Sosei Co Ltd Ord Company Name:
SOLTF Stock Symbol:
OTCMKTS Market:
Tokyo, Japan and Cambridge, UK, 27 March 2024 – Sosei Group Corporation (“the Company”; TSE: 4565) announces that the re-election of its Board of Directors and Executive Officers was approved at the Company’s 34th Annual Shareholders’ Meeting and a sub...
HTL0033744 has been designed by Sosei Heptares to promote mucosal healing and resolve inflammation in people with IBD Tokyo, Japan and Cambridge, UK, 21 March 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) announces...
GPR35 is a novel target with an established genetic association to IBD UK regulatory approval received to commence first-in-human studies Return of rights follows change in immunology research strategy by GSK Tokyo, Japan and Cambridge, UK, 21 March 2024 – Sos...